Hani O. Ghazi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Hani O. Ghazi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
A H Abu-Sabaah
1 shared publicationA.H. Abu-Sabaah
Department of Medical Microbiology, Faculty of Medicine and Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia
1 shared publication- A.H. Abu-Sabaah
Department of Medical Microbiology, Faculty of Medicine and Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
1 shared publication Abdulwahab M. Telmesani
1 shared publicationAl Hosni
Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Oman
1 shared publication- Ali Abdullah Al-Jabri
Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman
1 shared publication
Latest Publications
- Open Access
- 1 January 2007
- Published by Medknow in Journal of Family and Community Medicine
- Vol. 14 (1) , 15-7
Prevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in Makkah
To determine the seroprevalence rate of immunoglobulin G (IgG) and immunoglobulin M (IgM) to parvovirus B19 in pregnant Saudi women in Makkah. Using enzyme-linked immunosorbent assay (ELISA), a total of 1200 serum samples were tested for antibodies to parvovirus B19 known to cause a variety of clinical syndromes in women and newborn infants. Parvovirus B19 IgG antibodies detected in 46.6% and IgM antibodies were found in 2.25% of different age groups. The previous exposure to parvovirus B19 was determined, and 560 (46.6%) of 1200 pregnant Saudi women tested at their first antenatal visit were seropositive for specific IgG. The rate of maternal infection in susceptible pregnancies was 2.25%. These results were in accordance with previous studies performed in other countries.
- 1 January 2007
- Published by Medknow in Journal of Family and Community Medicine
- Vol. 14 (1) , 15-7
Open AccessPrevalence of antibodies to human parvovirus b19 in saudi women of childbearing age in Makkah
To determine the seroprevalence rate of immunoglobulin G (IgG) and immunoglobulin M (IgM) to parvovirus B19 in pregnant Saudi women in Makkah. Using enzyme-linked immunosorbent assay (ELISA), a total of 1200 serum samples were tested for antibodies to parvovirus B19 known to cause a variety of clinical syndromes in women and newborn infants. Parvovirus B19 IgG antibodies detected in 46.6% and IgM antibodies were found in 2.25% of different age groups. The previous exposure to parvovirus B19 was determined, and 560 (46.6%) of 1200 pregnant Saudi women tested at their first antenatal visit were seropositive for specific IgG. The rate of maternal infection in susceptible pregnancies was 2.25%. These results were in accordance with previous studies performed in other countries.
- Open Access
- 1 January 2006
- Published by Medknow in Journal of Family and Community Medicine
- Vol. 13 (2) , 61-4
Seropositivity of chlamydia trachomatis among saudi pregnant women in Makkah
To determine the seroprevalence rates of immunoglobulin G (IgG) and immunoglobulin M (IgM) to Chlamydia trachomatis in Saudi pregnant women. Using enzyme-linked immunosorbent assay (ELISA), a total of 1600 serum samples were tested for antibodies to Chlamydia trachomatis known to cause a variety of clinical syndromes in women and newborn infants. Chlamydia trachomatis IgG antibodies were detected in 8.7% and IgM antibodies were found in 1.5% of different age groups. Pregnant Saudi women have low prevalence rate of Chlamydia trachomatis IgG antibodies and lower prevalence for Chlamydia trachomatis IgM.
- 1 January 2006
- Published by Medknow in Journal of Family and Community Medicine
- Vol. 13 (2) , 61-4
Open AccessSeropositivity of chlamydia trachomatis among saudi pregnant women in Makkah
To determine the seroprevalence rates of immunoglobulin G (IgG) and immunoglobulin M (IgM) to Chlamydia trachomatis in Saudi pregnant women. Using enzyme-linked immunosorbent assay (ELISA), a total of 1600 serum samples were tested for antibodies to Chlamydia trachomatis known to cause a variety of clinical syndromes in women and newborn infants. Chlamydia trachomatis IgG antibodies were detected in 8.7% and IgM antibodies were found in 1.5% of different age groups. Pregnant Saudi women have low prevalence rate of Chlamydia trachomatis IgG antibodies and lower prevalence for Chlamydia trachomatis IgM.
- 1 January 2006
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 63 (4) , 155-158
Better diagnosis and treatment of throat infections caused by group A β-haemolytic streptococci
This study aims to assess the diagnostic value of a rapid streptococcal antigen test in addition to four clinical features in patients with sore throat, using throat culture and antibody titre as reference tests, and to evaluate the efficacy of the current antibiotics used in the treatment of throat infections caused by group A β-haemolytic streptococcus (GABHS). Four clinical features (fever [history of] ≥38˚C, lack of cough, tonsillar exudate, and anterior cervical lymphadenopathy) are recorded in 355 patients aged four years to ≥15 years. A rapid antigen diagnostic test (RADT) is performed, as well as a throat culture. Antistreptolysin O (ASO) titre is performed in patients ≥11 years. GABHS from patients are tested for susceptibility to different antibiotics. Throat cultures were positive for GABHS in 19% patients. Rapid tests were positive in 24%. Compared with throat culture, the rapid test gave a sensitivity of 91%, specificity of 91%, positive predictive value of 73% and a negative predictive value of 98%. For patients with three or four clinical features, however, the sensitivity was considerably higher at 97%. Using the ASO test as a reference, no association was found between RADT and culture results. Zithromax showed the highest prescription rate (25.5%) and produced a high cure rate (91%) in patients with GABHS pharyngitis.
- 1 January 2006
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 63 (4) , 155-158
Better diagnosis and treatment of throat infections caused by group A β-haemolytic streptococci
This study aims to assess the diagnostic value of a rapid streptococcal antigen test in addition to four clinical features in patients with sore throat, using throat culture and antibody titre as reference tests, and to evaluate the efficacy of the current antibiotics used in the treatment of throat infections caused by group A β-haemolytic streptococcus (GABHS). Four clinical features (fever [history of] ≥38˚C, lack of cough, tonsillar exudate, and anterior cervical lymphadenopathy) are recorded in 355 patients aged four years to ≥15 years. A rapid antigen diagnostic test (RADT) is performed, as well as a throat culture. Antistreptolysin O (ASO) titre is performed in patients ≥11 years. GABHS from patients are tested for susceptibility to different antibiotics. Throat cultures were positive for GABHS in 19% patients. Rapid tests were positive in 24%. Compared with throat culture, the rapid test gave a sensitivity of 91%, specificity of 91%, positive predictive value of 73% and a negative predictive value of 98%. For patients with three or four clinical features, however, the sensitivity was considerably higher at 97%. Using the ASO test as a reference, no association was found between RADT and culture results. Zithromax showed the highest prescription rate (25.5%) and produced a high cure rate (91%) in patients with GABHS pharyngitis.
- 1 January 2005
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 62 (2) , 92-93
Biomedical Science in Brief
(2005). Biomedical Science in Brief. British Journal of Biomedical Science: Vol. 62, No. 2, pp. 92-93.
- 1 January 2005
- Published by Frontiers Media SA in British Journal of Biomedical Science
- Vol. 62 (2) , 92-93
Biomedical Science in Brief
(2005). Biomedical Science in Brief. British Journal of Biomedical Science: Vol. 62, No. 2, pp. 92-93.
- 8 November 2002
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 11 (4) , 180-182
TORCH Agents in Pregnant Saudi Women
Objective: To determine the seroprevalence rates of IgG to common TORCH agents in pregnant Saudi women using indirect enzyme-linked immunosorbent assay. Subjects and Methods: A total of 926 samples of sera were tested for antibodies to TORCH agents known to cause serious congenital infections: Toxoplasma gondii, rubella, cytomegalovirus (CMV), herpes simplex viruses (HSV-1 and HSV-2), varicella zoster virus (VZV) and human immunodeficiency virus (HIV-1 and HIV-2). Results: Toxoplasma IgG antibodies were detected in 35.6%, CMV total IgG antibodies were found in 92.1%, rubella IgG antibodies in 93.3%, HSV-1 IgG antibodies in 90.9%, HSV-2 IgG in 27.1%, and VZV IgG antibodies in 74.4%. A 0% seroprevalence rate for HIV-1 and -2 was found. Conclusion: Pregnant Saudi women commonly have IgG antibodies to rubella, CMV, HSV-1 and -2, VZV, and T. gondii. Serological evidence of HIV infection was not observed.
- 8 November 2002
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 11 (4) , 180-182
TORCH Agents in Pregnant Saudi Women
Objective: To determine the seroprevalence rates of IgG to common TORCH agents in pregnant Saudi women using indirect enzyme-linked immunosorbent assay. Subjects and Methods: A total of 926 samples of sera were tested for antibodies to TORCH agents known to cause serious congenital infections: Toxoplasma gondii, rubella, cytomegalovirus (CMV), herpes simplex viruses (HSV-1 and HSV-2), varicella zoster virus (VZV) and human immunodeficiency virus (HIV-1 and HIV-2). Results: Toxoplasma IgG antibodies were detected in 35.6%, CMV total IgG antibodies were found in 92.1%, rubella IgG antibodies in 93.3%, HSV-1 IgG antibodies in 90.9%, HSV-2 IgG in 27.1%, and VZV IgG antibodies in 74.4%. A 0% seroprevalence rate for HIV-1 and -2 was found. Conclusion: Pregnant Saudi women commonly have IgG antibodies to rubella, CMV, HSV-1 and -2, VZV, and T. gondii. Serological evidence of HIV infection was not observed.